Skip to main content
School of Public Health
block W logo University of Washington

Beth E. Devine

Adjunct Professor, Health Services
Professor, Pharmacy (primary appt.)
Adjunct Professor, Biomedical Informatics and Medical Education
Adjunct Professor, Surgery


PhD   University of Washington, 2008   (Health Services Research)
MBA   University of San Francisco, 1999   (Business Admin Masters)
PharmD   University of The Pacific, 1978
BPHARM   University of The Pacific, 1975   (Pharmacy)

Contact Info


The Choice Institute
University of Washington
Seattle, WA 98195-7620

campus box:   357630
voice:   206-221-5760
fax:   206-543-3835


Beth Devine is a health services research scientist and health economist. She studies medication safety, specifically pharmacogenomic biomarker-guided medication use and adverse drug events using real world evidence from electronic health records. Her work draws from the disciplines of patient-centered outcomes research and clinical informatics; she employs methods from epidemiology, biostatistics, and decision analysis. Her second area of emphasis is evidence synthesis, network meta-analysis and network meta-analysis, wherein she teaches and mentors graduate students. Dr. Devine is an elected member of the Society for Research Synthesis Methods and served on the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Task Force that developed guidelines to conduct network meta-analyses.

Comparative effectiveness research; clinical research informatics; evidence synthesis; medication management; health information technology
  • HSERV 584
    Assessing Outcomes in Health and Medicine

Aronson S, Babb L, Ames D, Gibbs RA, Venner E, Connelly JJ, Marsolo K, Weng C, Williams MS, Hartzler AL, Liang WH, Ralston JD, Devine EB, Murphy S, Chute CG, Caraballo PJ, Kullo IJ, Freimuth RR, Rasmussen LV, Wehbe FH, Peterson JF, Robinson JR, Wiley K, Overby Taylor C; eMERGE Network EHRI Working Group. Empowering genomic medicine by establishing critical sequencing result data flows: the eMERGE example. J Am Med Inform Assoc. 2018 May 31. doi: 10.1093/jamia/ocy051. [Epub ahead of print]  PMID: 29860405

Devine EB, Van Eaton E, Zadworny ME, Symons R, Devlin A, Yanez D, Yetisgen M, Keyloun KR, Capurro D, Alfonso-Cristancho R, Flum DR, Tarczy-Hornoch P. Automating Electronic Clinical Data Capture for Quality Improvement and Research: The CERTAIN Validation Project of Real World Evidence. EGEMS (Wash DC). 2018 May 22;6(1):8. doi: 10.5334/egems.211.  PMID: 29881766    PMCID: PMC5983060
PubMed Central

Devine EB, Perfetto E, Pickard AS, Schumock GT, Segal JB, Cannon E, Gagnon JP, Brixner DI, Garrison LP, Murray MD. Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation. J Comp Eff Res. 2018 Feb;7(2):167-175. doi: 10.2217/cer-2017-0059. Epub 2018 Feb 21.  PMID: 29464964

Devine EB, Totten AM, Gorman P, Eden KB, Kassakian S, Woods S, Daeges M, Pappas M, McDonagh M, Hersh WR. Health Information Exchange Use (1990-2015): A Systematic Review. EGEMS (Wash DC). 2017 Dec 7;5(1):27. doi: 10.5334/egems.249.  PMID: 29881743    PMCID: PMC5983051
PubMed Central

Canestaro WJ, Hendrix N, Bansal A, Sullivan SD, Devine EB, Carlson JJ. Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis. J Clin Epidemiol. 2017 Dec;92:58-68. doi: 10.1016/j.jclinepi.2017.08.004. Epub 2017 Aug 31. Review.  PMID: 28842289

Graduate Certificate in Comparative Effectiveness Research

Comparative effectiveness research is a growing field that aims to generate evidence to improve health care decisions for patients and providers. It examines the benefits and risks of different medical or healthcare interventions, including drugs and medical technology. The results of these comparison studies are used by medical professionals to make better informed healthcare decisions and thereby improve patient care.